社区对硫酸作为生物标志物的共识,以支持神经病变性粘多糖糖症的加速批准
Joseph Muenzer1, Carole Ho2, Heather Lau3
1Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Molecular genetics and metabolism
|July 17, 2024
概括
粘多糖症 (MPS) 疾病是一种罕见的遗传疾病,导致认知能力下降. 一个研讨会探讨了使用脑脊液硫酸 (HS) 作为加速批准神经病性MPS新疗法的生物标志物.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学是一种遗传学.
- 神经科学是一个神经科学.
背景情况:
- 粘多糖症 (MPS) 是一种极为罕见的遗传性溶酶体储存疾病.
- 在MPS中酶缺乏导致糖氨基甘 (GAG) 积累,影响包括大脑在内的器官.
- 目前神经病性MPS的治疗方法没有解决认知障碍,这对治疗开发构成重大挑战.
研究的目的:
- 探索使用脑脊液 (CSF) 肝素硫酸盐 (HS) 作为加速批准神经病性MPS疾病治疗药物的生物标志物.
- 总结了里根-乌达尔基金会关于MPS和潜在的监管途径召开的一次研讨会的演讲.
- 为开发神经性MPS治疗方法的前进道路提供视角.
主要方法:
- 综述了FDA,患者倡导,研究和行业代表参与的公开研讨会的演讲.
- 讨论美国食品和药物管理局 (FDA) 2020年关于开发用于具有基质沉积的罕见疾病治疗方法的指南.
- 作为加速批准的生物标志物,CSF HS的案例研究探索.
主要成果:
- 神经变异性MPS疾病的特征是脑中肝素硫酸盐 (HS) 的积累.
- 美国食品和药物管理局的2020年指导方针为基于基质减少的加速批准提供了一个框架.
- 脑脊液 (CSF) HS被提议作为支持加速批准的相关生物标志物.
结论:
- 由于疾病的稀有性和异质性,开发神经病性MPS的治疗方法具有挑战性.
- 作为一个生物标志物,CSF HS显示出支持加速批准新的MPS疗法的承诺.
- 进一步探索和应用FDA的指导对于推进神经病性MPS的治疗开发至关重要.
相关概念视频
Glycosaminoglycans
4.8K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.8K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K


